The cardinal role of the phospholipase A(2)/cyclooxygenase-2/prostaglandin E synthase/prostaglandin E(2) (PCPP) axis in inflammostasis (Q37941508)

25 August 2017

1 reference

title

The cardinal role of the phospholipase A(2)/cyclooxygenase-2/prostaglandin E synthase/prostaglandin E(2) (PCPP) axis in inflammostasis (English)

1 reference

25 August 2017

A D Mancini

1

1 reference

PubMed ID

21964881

25 August 2017

J A Di Battista

series ordinal

2

1 reference

PubMed ID

21964881

25 August 2017

language of work or name

1 reference

1 October 2011

1 reference

25 August 2017

Inflammation Research

1 reference

25 August 2017

60

1 reference

25 August 2017

12

1 reference

25 August 2017

1083-1092

1 reference

https://scigraph.springernature.com/pub.10.1007/s00011-011-0385-7

25 August 2017

0 references

cites work

Molecular circuits of resolution: formation and actions of resolvins and protectins

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0385-7

Neutrophil depletion inhibits early and late monocyte/macrophage increase in lung inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0385-7

Regulation of macrophage activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0385-7

Dynamic interactions of macrophages with T cells during antigen presentation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0385-7

Novel omega -- 3-derived local mediators in anti-inflammation and resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0385-7

Molecular therapeutic targets in inflammation: cyclooxygenase and NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0385-7

Early growth response factor-1 mediates prostaglandin E2-dependent transcriptional suppression of cytokine-induced tumor necrosis factor-alpha gene expression in human macrophages and rheumatoid arthritis-affected synovial fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0385-7

Origins of prostaglandin E2: involvements of cyclooxygenase (COX)-1 and COX-2 in human and rat systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0385-7

Cellular prostaglandin E2 production by membrane-bound prostaglandin E synthase-2 via both cyclooxygenases-1 and -2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0385-7

Resolution of inflammation in murine autoimmune arthritis is disrupted by cyclooxygenase-2 inhibition and restored by prostaglandin E2-mediated lipoxin A4 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0385-7

The Role of Arachidonic Acid Oxygenation Products in Pain and Inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0385-7

Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0385-7

The prostaglandin E2 E-prostanoid 4 receptor exerts anti-inflammatory effects in brain innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0385-7

Lipid mediator class switching during acute inflammation: signals in resolution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0385-7

Cyclooxygenase-2 generates anti-inflammatory mediators from omega-3 fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0385-7

Hematopoietic prostaglandin D2 synthase controls the onset and resolution of acute inflammation through PGD2 and 15-deoxyDelta12 14 PGJ2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0385-7

Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0385-7

15-deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0385-7

Biosynthesis of 15-deoxy-delta12,14-PGJ2 and the ligation of PPARgamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0385-7

Role of PPAR-gamma in inflammation. Prospects for therapeutic intervention by food components

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0385-7

PPARγ Activation Primes Human Monocytes into Alternative M2 Macrophages with Anti-inflammatory Properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0385-7

Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0385-7

Peroxisome proliferator-activated receptor gamma is required for regulatory CD4+ T cell-mediated protection against colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0385-7

The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0385-7

Nimesulide, a preferential cyclooxygenase 2 inhibitor, suppresses peroxisome proliferator-activated receptor induction of cyclooxygenase 2 gene expression in human synovial fibroblasts: evidence for receptor antagonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0385-7

15d-PGJ2: the anti-inflammatory prostaglandin?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0385-7

Leukotriene B(4) BLT receptor signaling regulates the level and stability of cyclooxygenase-2 (COX-2) mRNA through restricted activation of Ras/Raf/ERK/p42 AUF1 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0385-7

Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0385-7

Anti-inflammatory role of microsomal prostaglandin E synthase-1 in a model of neuroinflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0385-7

Eicosanoid lipid mediators in fibrotic lung diseases: ready for prime time?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0385-7

Activity of the cyclooxygenase 2-prostaglandin-E prostanoid receptor pathway in mice exposed to house dust mite aeroallergens, and impact of exogenous prostaglandin E2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0385-7

Prostaglandin E2 suppresses chemokine production in human macrophages through the EP4 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0385-7

Chemokines and chemokine receptors in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0385-7

EP2/EP4 signalling inhibits monocyte chemoattractant protein-1 production induced by interleukin 1beta in synovial fibroblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0385-7

Prostaglandin E2 inhibits production of the inflammatory chemokines CCL3 and CCL4 in dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0385-7

Prostaglandin E2 inhibits TNF production in murine bone marrow-derived dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0385-7

Adenosine up-regulates cyclooxygenase-2 in human granulocytes: impact on the balance of eicosanoid generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0385-7

Collagen-induced arthritis is exacerbated in IL-10-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0385-7

Interleukin-10 inhibits osteoclastogenesis by reducing NFATc1 expression and preventing its translocation to the nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0385-7

Antiinflammatory effects of dexamethasone are partly dependent on induction of dual specificity phosphatase 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0385-7

Genetic and pharmacological analysis of prostanoid receptor function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0385-7

Prostaglandin E receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0385-7

Prostaglandin E(2) regulates the level and stability of cyclooxygenase-2 mRNA through activation of p38 mitogen-activated protein kinase in interleukin-1 beta-treated human synovial fibroblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0385-7

Resolution of inflammation: prostaglandin E2 dissociates nuclear trafficking of individual NF-kappaB subunits (p65, p50) in stimulated rheumatoid synovial fibroblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0385-7

AP-1 as a regulator of cell life and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0385-7

JunB is a gatekeeper for B-lymphoid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0385-7

JunB suppresses cell proliferation by transcriptional activation of p16(INK4a) expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0385-7

Resolvin E1 regulates inflammation at the cellular and tissue level and restores tissue homeostasis in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0385-7

Lipoxin A4 stable analogs are potent mimetics that stimulate human monocytes and THP-1 cells via a G-protein-linked lipoxin A4 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0385-7

Lipoxin A4 and B4 are potent stimuli for human monocyte migration and adhesion: selective inactivation by dehydrogenation and reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0385-7

Apoptotic neutrophils and T cells sequester chemokines during immune response resolution through modulation of CCR5 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0385-7

Resolvin E1 and protectin D1 activate inflammation-resolution programmes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0385-7

Macrophage-mediated 15-lipoxygenase expression protects against atherosclerosis development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0385-7

Reduced inflammation and tissue damage in transgenic rabbits overexpressing 15-lipoxygenase and endogenous anti-inflammatory lipid mediators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0385-7

Design of lipoxin A4 stable analogs that block transmigration and adhesion of human neutrophils.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0385-7

Local and systemic delivery of a stable aspirin-triggered lipoxin prevents neutrophil recruitment in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0385-7

Oxidoreductases in lipoxin A4 metabolic inactivation: a novel role for 15-onoprostaglandin 13-reductase/leukotriene B4 12-hydroxydehydrogenase in inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0385-7

Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0385-7

Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0385-7

Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0385-7

Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit peroxynitrite formation, NF-kappa B and AP-1 activation, and IL-8 gene expression in human leukocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0385-7

Post-transcriptional control of cyclooxygenase-2 gene expression. The role of the 3'-untranslated region

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0385-7

Site-specific proteolysis of cyclooxygenase-2: a putative step in inflammatory prostaglandin E(2) biosynthesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0385-7

Evidence that tristetraprolin binds to AU-rich elements and promotes the deadenylation and destabilization of tumor necrosis factor alpha mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0385-7

Analysis of the V(D)J recombination efficiency at lymphoid chromosomal translocation breakpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0385-7

Inherent instability of plasminogen activator inhibitor type 2 mRNA is regulated by tristetraprolin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0385-7

Structural and functional dissection of a conserved destabilizing element of cyclo-oxygenase-2 mRNA: evidence against the involvement of AUF-1 [AU-rich element/poly(U)-binding/degradation factor-1], AUF-2, tristetraprolin, HuR (Hu antigen R) or FBP1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0385-7

The stability of tristetraprolin mRNA is regulated by mitogen-activated protein kinase p38 and by tristetraprolin itself

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0385-7

Involvement of KSRP in the post-transcriptional regulation of human iNOS expression-complex interplay of KSRP with TTP and HuR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0385-7

Down-regulation of tristetraprolin expression results in enhanced IL-12 and MIP-2 production and reduced MIP-3alpha synthesis in activated macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0385-7

Control of mRNA decay by phosphorylation of tristetraprolin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0385-7

Inhibition of NF-kappaB and AP-1 activation by R- and S-flurbiprofen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0385-7

Nonsteroidal antiinflammatory drugs--differences and similarities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0385-7

The spectrum of gastrointestinal toxicity and effect on disease activity of selective cyclooxygenase-2 inhibitors in patients with inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0385-7

Prevalence and mechanism of nonsteroidal anti-inflammatory drug-induced clinical relapse in patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0385-7

Drug exposure and psoriasis vulgaris: case-control and case-crossover studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0385-7

Rofecoxib regulates the expression of genes related to the matrix metalloproteinase pathway in humans: implication for the adverse effects of cyclooxygenase-2 inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0385-7

Old and new generation lipid mediators in acute inflammation and resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0385-7

Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0385-7

Tristetraprolin (TTP)-14-3-3 complex formation protects TTP from dephosphorylation by protein phosphatase 2a and stabilizes tumor necrosis factor-alpha mRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0385-7

Chapter 17 Zymosan‐Induced Peritonitis as a Simple Experimental System for the Study of Inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0385-7

Regulation of neutrophil-derived IL-8: the role of prostaglandin E2, dexamethasone, and IL-4

21 January 2018

1 reference

12 December 2020

Monocyte retention and migration in pulmonary inflammation. Requirement for neutrophils

1 reference

12 December 2020

The organization and consequences of eicosanoid signaling

1 reference

12 December 2020

Prostaglandin I(2) and E(2) mediate the protective effects of cyclooxygenase-2 in a mouse model of immune-mediated liver injury

1 reference

12 December 2020

Interleukin-10 suppresses the development of collagen type II-induced arthritis and ameliorates sustained arthritis in rats

1 reference

12 December 2020

Prostaglandin E2 suppresses nuclear factor-kappaB mediated interleukin 15 production in rheumatoid synoviocytes

1 reference

12 December 2020

Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis. Protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction

1 reference

12 December 2020

NSAID gastropathy: the second most deadly rheumatic disease? Epidemiology and risk appraisal

1 reference

12 December 2020

Prostaglandins inhibit inflammatory mediator release from rat mast cells

1 reference

12 December 2020

HuA and tristetraprolin are induced following T cell activation and display distinct but overlapping RNA binding specificities

1 reference

12 December 2020

Cutting Edge: Lipoxins Rapidly Stimulate Nonphlogistic Phagocytosis of Apoptotic Neutrophils by Monocyte-Derived Macrophages

1 reference

12 December 2020

Lipoxin A4 inhibits IL-1 beta-induced IL-6, IL-8, and matrix metalloproteinase-3 production in human synovial fibroblasts and enhances synthesis of tissue inhibitors of metalloproteinases

1 reference

12 December 2020

Protective effects of inhaled PGE2 on allergen-induced airway responses and airway inflammation

1 reference

12 December 2020

IL-6: a regulator of the transition from neutrophil to monocyte recruitment during inflammation

1 reference

12 December 2020

Exacerbation of psoriasis induced by indomethacin

1 reference

12 December 2020

Absence of endogeneous interleukin-10 enhances the evolution of murine type-II collagen-induced arthritis.

1 reference

12 December 2020

Control by IFN-gamma and PGE2 of TNF alpha and IL-1 production by human monocytes

1 reference

12 December 2020

Synthesis of interleukin 1beta, tumor necrosis factor-alpha, and interstitial collagenase (MMP-1) is eicosanoid dependent in human osteoarthritis synovial membrane explants: interactions with antiinflammatory cytokines

1 reference

12 December 2020

Characterization of prostaglandin E2 generation through the cyclooxygenase (COX)-2 pathway in human neutrophils

1 reference

12 December 2020

The formation of a structure with the features of synovial lining by subcutaneous injection of air: an in vivo tissue culture system

1 reference

12 December 2020

Inducible cyclooxygenase may have anti-inflammatory properties

1 reference

12 December 2020

10.1007/S00011-011-0385-7

Identifiers

DOI

1 reference

25 August 2017

1 reference

PubMed ID

21964881